AsthmaNCT06197737
Specific Modified Exercise Program for Patients Having Chronic Asthma
A study testing Moderate Intensity Interval Training, Sprint Interval Training and pharmacological treatment in people with Asthma, run by Riphah International University at 1 site in Pakistan.
Trial summary
To compare the effects of moderate intensity interval training and sprint interval training on patients having chronic asthma. Read more about this study
- Who is it for?
- Ages 15 to 25 years
- Conditions the study is for
- Asthma
- What is being tested?
- Moderate Intensity Interval Training, Sprint Interval Training and pharmacological treatment
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 78 participants
- Where
- 1 sitePakistan
- Study dates
- 1 Mar 2023to 1 Jan 2024
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 15 to 25 years
- All sexes
- No healthy volunteers
- Child, Adult
Who may be able to join
- Patients having chronic asthma
- Age between 15-25 years.
- Participants having no dyspnea at rest .
- Participants scoring 13 or less on borg scale
Who cannot join
- History of co-morbidities.
- History of recent fractures.
- Participants scoring greater than 13 on BORG scale
- Exercise induced asthma (evaluated through BRUCE protocol).
- Individuals with co-morbidities related to any neurological, cardiovascular, psychological and musculoskeletal disorders .
- Patients score falling 15 or more on Borg scale.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Effects of Moderate Intensity Interval Training and Sprint Interval Training on Patients Having Chronic Asthma.
To compare the effects of moderate intensity interval training and sprint interval training on patients having chronic asthma.
Read the detailed description
Chronic asthma is a complex heterogeneous disease characterized by multiple aggravating factors. Asthma is treated with two types of medicines , long term medicines and quick relieve medicine. Although the relationship between asthma and the effects of HIIT/SIT were studied in the literature, there was not one comparing the results of these aforementioned studies. The purpose of this study is to find the effects of moderate intensity interval training and sprint interval training on pat determine effects of group wise physical activity on asthma related quality of life. To determine the effects of group wise physical activity on cardiorespiratory endurance
- Conditions
- Asthma
- Being tested
- Moderate Intensity Interval Training, Sprint Interval Training, pharmacological treatment
- Medical subject headings
- Asthma
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Moderate Intensity Interval TrainingOther
Participants in this group will perform moderate intensity interval training in which they will perform stair climbing 3 times a week and for every 1 interval I will ask them to take rest for 3 minutes.
Sprint Interval TrainingOther
sprint interval training in which they will do stair climbing 3 times a week with a fast pace.
pharmacological treatmentOther
They will be on pharmacological treatment as prescribed by their pulmonologist.
| Study group | Role | What they receive |
|---|---|---|
| Moderate Intensity Interval Training | Experimental | These participants will perform moderate intensity interval training. The intervention will be applied thrice a week. Moderate intensity interval training in which they do stair climbing 3 times a week And for every 1 interval I will ask them to take rest for 3 minutes. Receives: Other: Moderate Intensity Interval Training |
| Sprint Interval Training | Experimental | These participants will perform sprint interval training and frequency will be 3 days a week.
The participants will perform sprint interval training in which they will do stair climbing 3 times a week with a fast pace. Receives: Other: Sprint Interval Training |
| pharmacological treatment | Other | They will be on pharmacological treatment as prescribed by their pulmonologist. Receives: Other: pharmacological treatment |
What is being measured
The primary outcome is the main question the study is designed to answer.
Assessment of change in the Inspiratory Capacity
It will measured using an incentive spirometer
Measured: Baseline, 8th week and then 16th week
Assessment of change in the Pulmonary Function
Electronic spirometer will be used to measure all the parameters of pulmonary function.
Measured: Baseline, 8th week and then 16th week
Assessment of change in the Oxygen saturation
Measured using pulse oximeter before, during and after the intervention.
Measured: Baseline, 8th week and then 16th week
Assessment of change in the Rate of perceived exertion / dyspnea
measured through borg scale during the assigned intervention
Measured: Baseline, 8th week and then 16th week
Assessment of change in the cardiovascular endurance
PACER test for cardiovascular endurance test
Measured: Baseline, 8th week and then 16th week
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted9 Jan 2024
- Study start1 Mar 2023
- Primary completion1 Jan 2024
- Study completion1 Jan 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for AsthmaStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 78 participants (actual)
Sponsor and investigators
- Lead sponsor
- Riphah International University
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Malik Muhammad Ali Awan, MSPT, Principal investigator, Riphah International University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06197737
- Sponsor's protocol ID
- REC/MS-PT/01379
- Status last verified
- May 2024
- First submitted
- 4 May 2023
- Last updated
- 21 May 2024
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 21 May 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effects of Moderate Intensity Interval Training and Sprint Interval Training on Patients Having Chronic Asthma.
- ClinicalTrials.gov ID
- NCT06197737
- Acronym / sponsor ID
- REC/MS-PT/01379
- Conditions
- Asthma
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 78 participants (actual)
- Lead sponsor
- Riphah International UniversityUniversity, hospital or other
- Study start
- 1 Mar 2023 (actual)
- Primary completion
- 1 Jan 2024 (actual)
- Study completion
- 1 Jan 2024 (actual)
- First posted
- 9 Jan 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
To compare the effects of moderate intensity interval training and sprint interval training on patients having chronic asthma.
Detailed description
Chronic asthma is a complex heterogeneous disease characterized by multiple aggravating factors. Asthma is treated with two types of medicines , long term medicines and quick relieve medicine. Although the relationship between asthma and the effects of HIIT/SIT were studied in the literature, there was not one comparing the results of these aforementioned studies. The purpose of this study is to find the effects of moderate intensity interval training and sprint interval training on pat determine effects of group wise physical activity on asthma related quality of life. To determine the effects of group wise physical activity on cardiorespiratory endurance
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| Moderate Intensity Interval Training | Experimental | Other: Moderate Intensity Interval TrainingThese participants will perform moderate intensity interval training. The intervention will be applied thrice a week. Moderate intensity interval training in which they do stair climbing 3 times a week And for every 1 interval I will ask them to take rest for 3 minutes. |
| Sprint Interval Training | Experimental | Other: Sprint Interval TrainingThese participants will perform sprint interval training and frequency will be 3 days a week. The participants will perform sprint interval training in which they will do stair climbing 3 times a week with a fast pace. |
| pharmacological treatment | Other | Other: pharmacological treatmentThey will be on pharmacological treatment as prescribed by their pulmonologist. |
Who may qualify
- Ages
- 15 to 25 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult
Key inclusion criteria (4 listed)
- Patients having chronic asthma
- Age between 15-25 years.
- Participants having no dyspnea at rest .
- Participants scoring 13 or less on borg scale
Key exclusion criteria (6 listed)
- History of co-morbidities.
- History of recent fractures.
- Participants scoring greater than 13 on BORG scale
- Exercise induced asthma (evaluated through BRUCE protocol).
- Individuals with co-morbidities related to any neurological, cardiovascular, psychological and musculoskeletal disorders .
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Moderate Intensity Interval TrainingParticipants in this group will perform moderate intensity interval training in which they will perform stair climbing 3 times a week and for every 1 interval I will ask them to take rest for 3 minutes. | Other | Moderate Intensity Interval Training |
| Sprint Interval Trainingsprint interval training in which they will do stair climbing 3 times a week with a fast pace. | Other | Sprint Interval Training |
| pharmacological treatmentThey will be on pharmacological treatment as prescribed by their pulmonologist. | Other | pharmacological treatment |
Primary outcome
Assessment of change in the Inspiratory Capacity
Time frame: Baseline, 8th week and then 16th week
It will measured using an incentive spirometer
Assessment of change in the Pulmonary Function
Time frame: Baseline, 8th week and then 16th week
Electronic spirometer will be used to measure all the parameters of pulmonary function.
Assessment of change in the Oxygen saturation
Time frame: Baseline, 8th week and then 16th week
Measured using pulse oximeter before, during and after the intervention.
Assessment of change in the Rate of perceived exertion / dyspnea
Time frame: Baseline, 8th week and then 16th week
measured through borg scale during the assigned intervention
Assessment of change in the cardiovascular endurance
Time frame: Baseline, 8th week and then 16th week
PACER test for cardiovascular endurance test
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 21 May 2024.
- Individual participant dataSharing planned: No
Related trials for Asthma
Enrolling by invitationObservational study
Allergy, Asthma, and Atopic Eczema in Finland
Asthma, Asthma in Children
RecruitingPhase 2
Rademikibart IV for Acute Asthma and COPD Exacerbation
Asthma Acute, COPD Exacerbation Acute
Active, not recruiting
Community Health Equity Accelerator (CHEA) Pediatric Asthma Intervention
Asthma in Children
Enrolling by invitationObservational study
Firefighter's Longitudinal Airway and Respiratory Exposome/Multiome Study (FLARES)
Anosmia, Chronic Obstructive Pulmonary Disease
RecruitingObservational study
NHALES (Natural History of Asthma With Longitudinal Environmental Sampling)
Asthma
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Malik Muhammad Ali Awan, MSPT principal investigator
Riphah International University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Moderate Intensity Interval Training, Sprint Interval Training and pharmacological treatment in people with Asthma, run by Riphah International University at 1 site in Pakistan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 21 May 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Assessment of change in the Inspiratory Capacity (time frame: Baseline, 8th week and then 16th week). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 May 2024.